Literature DB >> 14211

Activation of the alternative pathway by pneumococcal cell walls.

J A Winkelstein, A Tomasz.   

Abstract

The present studies were performed in order to identify the pneumococcal subcellular component responsible for activating the alternative pathway. Purified pneumococcal cell walls were able to activate the alternative pathway at a concentration as low as 5 mug/ml and were more active than crude cell walls, which in turn were more active than the whole organism. Purified pneumococcal cell membranes also were able to activiate the alternative pathway but had less than 10% of the activity of the purified walls. Thus, the cell wall appears to play a major role in pneumococcal activation of the alternative pathway. Pneumococcal cell walls containing ethanolamine were as effective as cell walls containing choline in activating the alternative pathway. Since C-reactive protein binds specifically to the phosphorylcholine residue of pneumococcal C-polysaccharide, it is unlikely that pneumococcal cell walls must combine with C-reactive protein in order to activate the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14211

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Interaction of pneumococcal antigens with complement in rats.

Authors:  J D Coonrod; S Jenkins
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components.

Authors:  I Riesenfeld-Orn; S Wolpe; J F Garcia-Bustos; M K Hoffmann; E Tuomanen
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Characterization of cell wall polymers secreted into the growth medium of lysis-defective pneumococci during treatment with penicillin and other inhibitors of cell wall synthesis.

Authors:  R Hakenbeck; S Waks; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

5.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

6.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.

Authors:  F T Saulsbury; J A Winkelstein
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

9.  Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.

Authors:  E J Brown; K A Joiner; R M Cole; M Berger
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.